Barclays raised the firm’s price target on Stryker (SYK) to $469 from $462 and keeps an Overweight rating on the shares. The firm sees “ample upside” to the company’s fiscal 2026 growth estimates “without pushing the model.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker (SYK) Earnings Call Highlights Growth and Resilience
- Stryker price target raised to $454 from $448 at Needham
- Stryker price target lowered to $437 from $450 at Baird
- Stryker price target raised to $412 from $410 at BTIG
- Stryker: Sustained Double-Digit Growth and Operating Leverage Support Buy Rating Despite 2026 Tariff Headwinds
